Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Death receptors.

Wajant H.

Essays Biochem. 2003;39:53-71. Review.

PMID:
14585074
3.

Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF.

Grell M, Zimmermann G, Gottfried E, Chen CM, Grünwald U, Huang DC, Wu Lee YH, Dürkop H, Engelmann H, Scheurich P, Wajant H, Strasser A.

EMBO J. 1999 Jun 1;18(11):3034-43.

5.

Modulation of death receptor pathways in oncology.

de Vries EG, Timmer T, Mulder NH, van Geelen CM, van der Graaf WT, Spierings DC, de Hooge MN, Gietema JA, de Jong S.

Drugs Today (Barc). 2003;39 Suppl C:95-109. Review.

PMID:
14988748
6.

Death receptors as targets of cancer therapeutics.

Sheikh MS, Huang Y.

Curr Cancer Drug Targets. 2004 Feb;4(1):97-104. Review.

PMID:
14965271
7.

Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.

Farrell GC, Larter CZ, Hou JY, Zhang RH, Yeh MM, Williams J, dela Pena A, Francisco R, Osvath SR, Brooling J, Teoh N, Sedger LM.

J Gastroenterol Hepatol. 2009 Mar;24(3):443-52. doi: 10.1111/j.1440-1746.2009.05785.x.

PMID:
19226377
8.

Biochemical analysis of the native TRAIL death-inducing signaling complex.

Walczak H, Haas TL.

Methods Mol Biol. 2008;414:221-39. Review.

PMID:
18175822
9.

Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and -2.

Benedict CA, Norris PS, Prigozy TI, Bodmer JL, Mahr JA, Garnett CT, Martinon F, Tschopp J, Gooding LR, Ware CF.

J Biol Chem. 2001 Feb 2;276(5):3270-8.

10.

Signaling and subcellular localization of the TNF receptor Edar.

Koppinen P, Pispa J, Laurikkala J, Thesleff I, Mikkola ML.

Exp Cell Res. 2001 Oct 1;269(2):180-92.

PMID:
11570810
11.

Death receptors and ligands in cervical carcinogenesis: an immunohistochemical study.

Reesink-Peters N, Hougardy BM, van den Heuvel FA, Ten Hoor KA, Hollema H, Boezen HM, de Vries EG, de Jong S, van der Zee AG.

Gynecol Oncol. 2005 Mar;96(3):705-13.

PMID:
15721415
12.

Structural determinants of DISC function: new insights into death receptor-mediated apoptosis signalling.

Sessler T, Healy S, Samali A, Szegezdi E.

Pharmacol Ther. 2013 Nov;140(2):186-99. doi: 10.1016/j.pharmthera.2013.06.009. Review.

PMID:
23845861
13.

Catalytically active Yersinia outer protein P induces cleavage of RIP and caspase-8 at the level of the DISC independently of death receptors in dendritic cells.

Gröbner S, Adkins I, Schulz S, Richter K, Borgmann S, Wesselborg S, Ruckdeschel K, Micheau O, Autenrieth IB.

Apoptosis. 2007 Oct;12(10):1813-25.

PMID:
17624595
14.

Involvement of tumor necrosis factor-alpha receptor 1 and tumor necrosis factor-related apoptosis-inducing ligand-(TRAIL) receptor-2/DR-5, but not Fas, in graft injury in live-donor liver transplantation.

Tashiro H, Itamoto T, Ohdan H, Arihiro K, Tateaki Y, Nakahara H, Ochi M, Hino H, Mizunuma K, Hara H, Tokita D, Onoe T, Ishiyama K, Mitsuta H, Sugino K, Asahara T.

Transpl Int. 2004 Nov;17(10):626-33.

15.

Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.

Song JH, Bellail A, Tse MC, Yong VW, Hao C.

J Neurosci. 2006 Mar 22;26(12):3299-308. Erratum in: J Neurosci. 2006 May 3;26(18):4983.

17.
18.

Transducing signals of life and death.

Yuan J.

Curr Opin Cell Biol. 1997 Apr;9(2):247-51. Review.

PMID:
9069264
19.

TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies.

MacFarlane M, Kohlhaas SL, Sutcliffe MJ, Dyer MJ, Cohen GM.

Cancer Res. 2005 Dec 15;65(24):11265-70.

20.
Items per page

Supplemental Content

Support Center